Gilbert F. Amelio's Insider Trades & SAST Disclosures

Gilbert F. Amelio's most recent trade in Galectin Therapeutics Inc was a trade of 50,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 24, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Galectin Therapeutics Inc
Gilbert Amelio F. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2024 50,000 50,000 - - Stock Option (right to buy)
Galectin Therapeutics Inc
Gilbert F. Amelio Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2023 40,000 40,000 - - Stock Option (right to buy)
Galectin Therapeutics Inc
Gilbert F. Amelio Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2022 40,000 40,000 - - Stock Option (right to buy)
Galectin Therapeutics Inc
Gilbert F. Amelio Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2021 70,000 70,000 - - Stock option (right to buy)
Galectin Therapeutics Inc
Gilbert F. Amelio Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2021 40,000 40,000 - - Stock option (right to buy)
Galectin Therapeutics Inc
Gilbert F. Amelio Director Sale of securities on an exchange or to another person at price $ 2.17 per share. 11 Jan 2021 60,000 60,614 (0%) 0% 2.2 130,200 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades